Tango Therapeutics, Inc. · NASDAQ:TNGX
Gall Matthew received 40,000 Tango Therapeutics, Inc. shares as an award (Form 4)
Traded May 1, 2026 · Filed May 5, 2026
On May 1, 2026, Gall Matthew (Chief Financial Officer) received 40,000 Tango Therapeutics, Inc. shares as an award, leaving 40,000 shares. Filed May 5, 2026 (Form 4).
- Awarded
- 40,000 shares
- Holding after
- 40,000 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 1, 2026 | Common Stock | Award | 40,000 | 40,000 | Direct |